# Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

> **NCT06531278** · PHASE2 · RECRUITING · sponsor: **Jiang Long** · enrollment: 40 (estimated)

## Conditions studied

- Pancreatic Cancer Metastatic to Liver

## Interventions

- **DRUG:** Irinotecan liposome
- **DRUG:** Adebrelimab
- **DRUG:** Oxaliplatin
- **DRUG:** Fluorouracil
- **DRUG:** Calcium folinate

## Key facts

- **NCT ID:** NCT06531278
- **Lead sponsor:** Jiang Long
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531278, "Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06531278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*